Miyata T, Fu M X, Kurokawa K, van Ypersele de Strihou C, Thorpe S R, Baynes J W
Molecular and Cellular Nephrology, Institute of Medical Sciences and Department of Internal Medicine, Tokai University School of Medicine, Isehara, Kanagawa, Japan.
Kidney Int. 1998 Oct;54(4):1290-5. doi: 10.1046/j.1523-1755.1998.00093.x.
Advanced glycation end products (AGEs), formed by non-enzymatic glycation and oxidation (glycoxidation) reactions, have been implicated in the pathogenesis of several diseases, including normoglycemic uremia. AGE research in uremia has focused on the accumulation of carbohydrate-derived adducts generated by the Maillard reaction. Recent studies, however, have demonstrated that one AGE, the glycoxidation product carboxymethyllysine (CML), could be derived not only from carbohydrates but also from oxidation of polyunsaturated fatty acids in vitro, raising the possibility that both carbohydrate and lipid autoxidation might be increased in uremia.
To address this hypothesis, we applied gas chromatography-mass spectrometry and high performance liquid chromatography to measure protein adducts formed in uremic plasma by reactions between carbonyl compounds and protein amino groups: pentosidine derived from carbohydrate-derived carbonyls, malondialdehyde (MDA)-lysine derived from lipid-derived carbonyls, and CML originating possibly from both sources.
All three adducts were elevated in uremic plasma. Plasma CML levels were mainly (>95%) albumin bound. Their levels were not correlated with fructoselysine levels and were similar in diabetic and non-diabetic patients on hemodialysis, indicating that their increase was not driven by glucose. Pentosidine and MDA-lysine were also increased in plasma to the same extent in diabetic and non-diabetic hemodialysis patients. Statistical analysis indicated that plasma levels of CML correlated weakly (P < 0.05) with those of pentosidine and MDA-lysine, but that pentosidine and MDA-lysine varied independently (P > 0.5).
These data suggest that the increased levels of AGEs in blood, and probably in tissues, reported in uremia implicate a broad derangement in non-enzymatic biochemistry involving alterations in autoxidation of both carbohydrates and lipids.
晚期糖基化终末产物(AGEs)由非酶糖基化和氧化(糖氧化)反应形成,与包括正常血糖尿毒症在内的多种疾病的发病机制有关。尿毒症中AGE的研究主要集中在美拉德反应产生的碳水化合物衍生加合物的积累上。然而,最近的研究表明,一种AGE,即糖氧化产物羧甲基赖氨酸(CML),不仅可以来源于碳水化合物,还可以来源于体外多不饱和脂肪酸的氧化,这增加了尿毒症中碳水化合物和脂质自氧化可能均增加的可能性。
为验证这一假设,我们应用气相色谱-质谱联用技术和高效液相色谱法来测量尿毒症血浆中羰基化合物与蛋白质氨基反应形成的蛋白质加合物:来源于碳水化合物羰基的戊糖苷、来源于脂质羰基的丙二醛(MDA)-赖氨酸,以及可能来源于这两种来源的CML。
尿毒症血浆中这三种加合物均升高。血浆CML水平主要(>95%)与白蛋白结合。它们的水平与果糖赖氨酸水平无关,在接受血液透析的糖尿病和非糖尿病患者中相似,表明它们的增加并非由葡萄糖驱动。糖尿病和非糖尿病血液透析患者血浆中的戊糖苷和MDA-赖氨酸也有相同程度的增加。统计分析表明,血浆CML水平与戊糖苷和MDA-赖氨酸水平弱相关(P<0.05),但戊糖苷和MDA-赖氨酸各自独立变化(P>0.5)。
这些数据表明,尿毒症中血液以及可能在组织中AGEs水平的升高意味着非酶生物化学的广泛紊乱,涉及碳水化合物和脂质自氧化的改变。